Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,543.51 +2,200.03 (+4.05%) CMC Crypto 200
1,174.93 -33.76 (-2.79%)
Monte Rosa Therapeutics, Inc. (GLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.8900 |
| Open | 3.8300 |
| Bid | 3.6000 x 100 |
| Ask | 3.7000 x 400 |
| Day's range | 3.6100 - 3.9000 |
| 52-week range | 2.4400 - 8.8400 |
| Volume | |
| Avg. volume | 218,312 |
| Market cap | 222.588M |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Institutional investors own a significant stake of 40% in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
Key Insights Institutions' substantial holdings in Monte Rosa Therapeutics implies that they have significant influence...
- GuruFocus.com
Monte Rosa Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Insight into Financial Performance and Strategic Developments Amidst Ongoing Clinical Trials
- Zacks
Recent Price Trend in Monte Rosa Therapeutics (GLUE) is Your Friend, Here's Why
Monte Rosa Therapeutics (GLUE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
© 2024 Yahoo. All rights reserved.